Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076.SS)
CNY 49.04
(-1.9%)
CNY 49.04
(-1.9%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 324.76 Million CNY | 32.14% |
| 2022 | 237.28 Million CNY | 4.89% |
| 2021 | 221.02 Million CNY | -3.49% |
| 2020 | 236.27 Million CNY | 121.25% |
| 2019 | 107.59 Million CNY | 62.98% |
| 2018 | 60.12 Million CNY | -22.14% |
| 2017 | 82.55 Million CNY | 243.7% |
| 2016 | -58.8 Million CNY | -292.75% |
| 2015 | -15.73 Million CNY | -35.84% |
| 2014 | -10.92 Million CNY | 8.7% |
| 2013 | -10.8 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 96.5 Million CNY | 22.61% |
| 2024 Q3 | 137.48 Million CNY | -41.34% |
| 2024 Q2 | 230.33 Million CNY | 92.85% |
| 2023 Q4 | 100.77 Million CNY | 20.78% |
| 2023 FY | - CNY | 32.14% |
| 2023 Q1 | 29.78 Million CNY | -68.25% |
| 2023 Q2 | 38.18 Million CNY | 28.23% |
| 2023 Q3 | 83.43 Million CNY | 118.47% |
| 2022 Q4 | 93.8 Million CNY | 944.05% |
| 2022 FY | - CNY | 4.89% |
| 2022 Q2 | 22.72 Million CNY | 15.78% |
| 2022 Q1 | 19.62 Million CNY | -58.4% |
| 2022 Q3 | 8.98 Million CNY | -60.47% |
| 2021 FY | - CNY | -3.49% |
| 2021 Q4 | 47.18 Million CNY | 55.01% |
| 2021 Q2 | 21.59 Million CNY | -56.55% |
| 2021 Q3 | 30.44 Million CNY | 40.98% |
| 2021 Q1 | 49.69 Million CNY | 122.95% |
| 2020 Q1 | 5.28 Million CNY | -71.55% |
| 2020 Q4 | -216.53 Million CNY | -236.66% |
| 2020 FY | - CNY | 121.25% |
| 2020 Q2 | 60.68 Million CNY | 1048.65% |
| 2020 Q3 | 158.44 Million CNY | 161.09% |
| 2019 Q3 | 18.98 Million CNY | -14.33% |
| 2019 FY | - CNY | 62.98% |
| 2019 Q4 | 18.57 Million CNY | -2.17% |
| 2019 Q2 | 22.15 Million CNY | 173.82% |
| 2019 Q1 | 8.09 Million CNY | 153.04% |
| 2018 Q4 | -15.25 Million CNY | -404.47% |
| 2018 FY | - CNY | -22.14% |
| 2018 Q1 | 1.97 Million CNY | -92.73% |
| 2018 Q2 | 52.54 Million CNY | 2562.73% |
| 2018 Q3 | 5.01 Million CNY | -90.46% |
| 2017 Q3 | 21.95 Million CNY | -24.62% |
| 2017 FY | - CNY | 243.7% |
| 2017 Q1 | 2.23 Million CNY | 109.4% |
| 2017 Q4 | 27.12 Million CNY | 23.56% |
| 2017 Q2 | 29.12 Million CNY | 1201.92% |
| 2016 Q2 | -5.08 Million CNY | 0.0% |
| 2016 Q4 | -23.79 Million CNY | 0.0% |
| 2016 Q3 | -23.79 Million CNY | -368.17% |
| 2016 Q1 | -5.08 Million CNY | -14.72% |
| 2016 FY | - CNY | -292.75% |
| 2015 Q1 | -3.43 Million CNY | 0.0% |
| 2015 Q2 | -3.43 Million CNY | -0.0% |
| 2015 Q4 | -4.42 Million CNY | 0.0% |
| 2015 FY | - CNY | -35.84% |
| 2015 Q3 | -4.42 Million CNY | -28.86% |
| 2014 FY | - CNY | 8.7% |
| 2013 FY | - CNY | 0.0% |